Verition Fund Management’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
Verition Fund Management's DVAX Position: Q1 2026 in Review
Verition Fund Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 100,100 shares — an estimated $1.54M sold.
Verition Fund Management first reported a position in DVAX in Q4 2013 and held it in 10 quarters. The position peaked at $2.7M in Q1 2022. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Verition Fund Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Verition Fund Management sold 100,100 Dynavax Technologies shares in Q1 2026, an estimated $1.54M.
- Verition Fund Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 10 quarters.
- Verition Fund Management's Dynavax Technologies position peaked at $2.7M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.